Meeting News

Glaukos leverages acquisitions to enter new ophthalmology spaces

January 16, 2020
With recent acquisitions, Glaukos now has multiple products in development that expand its reach outside of the glaucoma space and into more…

Meeting News

Oyster Point’s dry eye nasal spray meets phase 2 endpoints

January 15, 2020
Oyster Point Pharma’s nasal spray treatment for dry eye disease has met its primary endpoints in the phase 2 MYSTIC trial, CEO and President…

CustomFlex artificial iris receives transitional pass-through payment status

January 15, 2020
The CustomFlex artificial iris was granted transitional pass-through payment status from CMS, effective Jan. 1, 2020. The artificial iris from VEO…

LumiThera completes Series C funding tranche

January 15, 2020
LumiThera has completed the second tranche of its Series C funding round to support clinical testing and commercialization of the Valeda light…

Meeting News

Santen plans entry in US glaucoma market

January 14, 2020
Santen plans to break into the U.S. glaucoma market in 2020 with the introduction of the DE-128 microshunt, according to a speaker at the 38th annual…

2020 AAO president begins term

January 13, 2020
Anne L. Coleman, MD, PhD, the American Academy of Ophthalmology’s 2020 president, has begun her term, according to a press release. Coleman…

ICYMI: Last week’s leading headlines

January 12, 2020
Keep up to date with the big news in ophthalmology. Here are some important stories you might have missed on from the past week:

Tarsus raises $60 million in Series B financing

January 10, 2020
Tarsus Pharmaceuticals announced the completion of $60 million in Series B financing that will be used to initiate a phase 2b/3 trial of topical…

Eyevensys closes on $30 million Series B financing

January 10, 2020
Eyevensys, a Paris-based biotechnology company, has closed a round of $30 million in Series B financing intended for development of EYS606 for the…

Alimera refinances debt with Solar Capital

January 6, 2020
Alimera Sciences has entered into a new $45 million term loan agreement with Solar Capital Partners, refinancing its debt facility, according to a…

EyeGate completes $5 million registered direct offering

January 6, 2020
EyeGate Pharmaceuticals has completed a registered direct offering totaling $5 million, according to a press release. Priced at-the-market under…

A look at 20 important ophthalmology articles of the past decade

January 2, 2020
As a new decade begins, looks back at some of our biggest stories in the past 10 years. Over the years, ophthalmology has evolved to…

CMS issues permanent J-code for Beovu

December 31, 2019
Beovu, Novartis’ wet age-related macular edema treatment, has been granted a permanent J-code from CMS, effective Jan. 1, 2020. Beovu…

Selling consultations on Amazon: Prize-winning strategy with social impact

Ocular Surgery News U.S. Edition, December 25, 2019
Selling consultations on Amazon may be an innovative strategy for reaching patients at an age when cataract develops, with benefits for both the…

Aequus, Medicom join to commercialize products in US

December 18, 2019
Aequus Pharmaceuticals and Medicom Healthcare have entered into an exclusive agreement to commercialize ophthalmology products in the United States…


Roche completes acquisition of Spark

December 17, 2019
Spark Therapeutics has accepted a tender offer for all outstanding shares of common stock at a price of $114.50 per share, allowing Roche to complete…

UK authority clears Roche acquisition of Spark

December 16, 2019
The U.K. Competition and Markets Authority has cleared Roche’s pending acquisition of Spark Therapeutics, ruling the deal would not negatively…

Johnson & Johnson Vision names new worldwide surgical vision president

December 11, 2019
Warren Foust has been named as worldwide president of Surgical Vision at Johnson & Johnson Vision, taking over from Tom Frinzi, who will…

Notal Vision completes $25 million in funding

December 11, 2019
Ganot Capital has extended a funding round to Notal Vision to $25 million to support the growth of the company’s ForeseeHome AMD monitoring…


ImprimisRx outsourcing facility receives California license

December 11, 2019
An FDA-registered 503B outsourcing facility for ImprimisRx has received a non-resident operating license from the state of California, the company…